Evidence map›Paper›PMID 42091260›Full record

ArticleJournal of thrombosis and haemostasis : JTH2026

Atherogenic apolipoprotein C-III may not be as bad as we thought.

Alexis N Smith, Ziyu Zhang, Ze Zheng

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Journal of thrombosis and haemostasis : JTH, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Alexis N SmithThrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, USA; Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Electronic address: ansmith2@Versiti.org.
Ziyu ZhangThrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, USA; Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA.
Ze ZhengThrombosis and Hemostasis Program, Versiti Blood Research Institute, Milwaukee, Wisconsin, USA; Cardiovascular Research Center, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Department of Medicine, Medical College of Wisconsin, Milwaukee, Wisconsin, USA; Department of Physiology, Medical College of Wisconsin, Milwaukee, Wisconsin, USA. Electronic address: zzheng@mcw.edu.

Funding

Training in Signature Transdisciplinary Cardiovascular SciencesT32HL134643 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Justin L Grobe, Jacquelyn P Kulinski · 2017 to 2026
$4.2M
The role of hepatocyte tPA in hepatic VLDL production.R01HL163516 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Ze Zheng · 2022 to 2026
$2.7M
The role of LDL in hemostasisR01HL174609 · NHLBI · MEDICAL COLLEGE OF WISCONSIN · PI Lynn Marie Malec, Ze Zheng · 2025 to 2026
$1.4M
NHLBI NIH HHS R01 HL163516NHLBI NIH HHS R01 HL174609NHLBI NIH HHS T32 HL134643
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42091260
PMCPMC13545815

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.